Shanghai Yizhong Pharmaceutical Co (SHSE:688091) ROCE % : -0.20% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai Yizhong Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai Yizhong Pharmaceutical Co's annualized ROCE % for the quarter that ended in Sep. 2024 was -0.20%.

Shanghai Yizhong Pharmaceutical Co ROCE % Historical Data

The historical data trend for Shanghai Yizhong Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Yizhong Pharmaceutical Co ROCE % Chart

Shanghai Yizhong Pharmaceutical Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-131.29

-8.44

-1.22

11.94

13.40

Shanghai Yizhong Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															8.57	9.84	9.08	1.56	-0.20

Shanghai Yizhong Pharmaceutical Co ROCE % Calculation

Shanghai Yizhong Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	187.17	/	( ( (1354.594 - 29.864)	+	(1573.359 - 103.984) )	/ 2 )
	=	187.17	/	( (1324.73	+	1469.375)	/ 2 )
	=	187.17	/	1397.0525
	=	13.40 %

Shanghai Yizhong Pharmaceutical Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-2.924	/	( ( (1535.585 - 71.3)	+	(1488.082 - 46.961) )	/ 2 )
	=	-2.924	/	( ( 1464.285	+	1441.121 )	/ 2 )
	=	-2.924	/	1452.703
	=	-0.20 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Shanghai Yizhong Pharmaceutical Co (SHSE:688091) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shanghai Yizhong Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Shanghai Yizhong Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Yizhong Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Yizhong Pharmaceutical Co Ltd (SHSE:688091) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

79 Renqi Road, Fengxian District, Shanghai, CHN, 201403

Website

http://www.yizhongpharma.com

Shanghai Yizhong Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating research and development, production and sales. It is committed towards the development of new dosage forms of anti-tumor drugs and related products.

Executives

Liu Gang	Core technical personnel
Qiu Yi	Core technical personnel
Du Xue Hang	Director
Sun Jing	Directors, senior managers, core technical personn
Zhou Jin Song	Directors, senior managers, core technical personn
Li Duan	Directors, senior managers, core technical personn

Shanghai Yizhong Pharmaceutical Co Headlines

No Headlines